Purity is a reported measurement, not a blanket verdict
“99% purity” sounds simple, but it compresses several important questions: what sample was tested, which method was used, how was the result calculated, and what other attributes were or were not measured? A useful reading begins by keeping the conclusion narrow.
A certificate is more informative when it connects a named material and lot to a visible method, acceptance criterion, result, date and issuer. Without that context, a percentage may be a claim or an example rather than a traceable result for current inventory.
What a percentage usually describes
On many peptide documents, a purity percentage is associated with a chromatographic result, often labelled HPLC. Chromatography separates components under specific conditions and can generate a reported proportion from the observed signal. The reported value is therefore tied to the procedure, the sample and the reporting approach.
Read the document for the method name, sample or lot identifier, test date, specification and actual result. “Specification: not less than 98.0%; result: 99.1%” is more informative than an isolated “99% purity” label because it shows both the stated threshold and the result.
Why a high number still has limits
A high reported number does not identify every other component in a sample. It also does not tell the reader that every relevant attribute was tested. Water content, residual solvents, microbial attributes, endotoxin, stability, container integrity and chain of custody are separate questions that need their own evidence when relevant.
Analytical guidance treats characteristics such as specificity, accuracy, precision and reportable range as separate parts of a procedure’s performance. This is one reason a method label or headline percentage is not the same thing as a complete quality assessment.
Purity, identity and amount are different questions
| Question | What can help answer it | What it does not settle by itself |
|---|---|---|
| Is this consistent with the stated material? | Identity-related result, such as molecular-mass information, for the named sample. | Overall purity, traceability or suitability for a particular use. |
| What proportion was reported under a stated procedure? | A chromatographic method, specification and numerical result. | The identity of every other component or every untested attribute. |
| How much material is present? | An assay or quantity result with its method and units. | Purity, identity or long-term stability unless those are separately reported. |
Different methods can be complementary. The key is not to make one reported field answer a question that belongs to another method or another document.
Four checks beside any percentage
- Lot match: can the COA be connected to the exact product lot?
- Method: does the document state how the result was obtained?
- Specification and result: are the acceptance limit and observed value both visible?
- Issuer and date: is there a named issuer and a meaningful test, issue or release date?
If one of these is missing, record it as missing or unclear. A document can still be useful evidence, but its limits should remain visible.
Common overreadings to avoid
- “99% means the remaining 1% is fully known.” Not from the percentage alone.
- “A purity result proves identity.” Identity and purity are separate analytical questions.
- “A high result proves the supplier is reliable overall.” One lot-specific result does not establish a broad company-level conclusion.
- “A COA proves safety or human suitability.” It does not; those are different questions requiring different evidence.
How to use the result in a supplier comparison
When comparing supplier evidence, describe exactly what is public: for example, “a lot-specific COA shows an HPLC-labelled purity result and visible batch number.” Keep a separate note for what is not shown, such as a missing lab identity, unclear date or absent method detail. This keeps documentation useful without turning it into an unsupported trust claim.
For a wider reading framework, see How to Read a Peptide COA: 7 Evidence Checks and HPLC and Mass Spectrometry on a Peptide COA.
Sources and further reading
- FDA: Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients — certificate fields, batch identification and supplier documentation.
- ICH Q2(R2): Validation of Analytical Procedures — analytical-procedure performance characteristics.
- NCBI Bookshelf: High-Performance Liquid Chromatography — general background on chromatographic separation.